Antisense compound and method for selectively killing activated T cells

Details for Australian Patent Application No. 2004276334 (hide)

Owner AVI BioPharma, Inc.

Inventors Moulton, Hong Mu; Hinrichs, David J.; Mourich, Dan V.; Iversen, Patrick L.

Agent Davies Collison Cave

Pub. Number AU-B-2004276334

PCT Pub. Number WO2005/030799

Priority 60/505,418 23.09.03 US

Filing date 23 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 16 September 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030799 Priority application(s): WO2005/030799

16 September 2010 Application Accepted

  Published as AU-B-2004276334

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276337-Inhibitors of histone deacetylase

2004276332-Substituted indole acid derivatives and their use as PAI-1 inhibitors